Answer
Pomalidomide has a median plasma half-life of approximately 7.5 hours in patients with multiple myeloma.
Sources for this answer
- Pomalidomide Zentiva 1mg hard capsZentiva · emc · SmPC §5.2 Pharmacokinetic properties · Version 1Document updated
Sources checked